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Abstract 
Background: Atopic dermatitis is a global problem affecting children, and its prevalence in Korea is steadily 
increasing. Since it is a chronically relapsing inflammatory skin disease, caregiver management of young 
children's atopic dermatitis is crucial for positive treatment outcomes. A factor that contributes to adherence to 
recommended prescriptions is parents’ self-efficacy. However, accurate measurements of parental self-efficacy 
in relation to disease-specific task management are scarce.  
Objectives: This study examined the psychometric properties of the Korean language version of the Parental 
Self-Efficacy with Eczema Care Index (K-PASECI). 
Methods: One hundred twenty five mothers of children younger than 13 years old who had atopic dermatitis 
were recruited from three tertiary hospitals across Korea. The K-PASECI was developed in accordance with the 
published guidelines. Psychometric testing included factor analysis, internal consistency testing, and concurrent 
validity analysis by comparing K-PASECI domains with parenting self-efficacy subscales.  
Results: Factor analysis revealed a four-factor structure that explained 69.4% of the variance. The four factors 
were as follows; managing a child’s symptoms and behaviour, communicating with medical staff, managing 
medication, and using moisturizer as part of routine management. The findings showed acceptable internal 
consistency (α=.94) and a moderate positive correlation with parenting self-efficacy (r=.48, p<.001).  
Conclusion: The K-PASECI, a reliable and valid scale for measuring self-efficacy in parents caring for children 
with atopic dermatitis, may be used in clinical and research settings to measure parents’ self-efficacy in Korea, 
as well as in other English-speaking countries.  
Keywords: atopic, child welfare, dermatitis, eczema, psychometrics, self-efficacy 
1. Introduction 
Atopic dermatitis, often called “atopic eczema,” is a chronically relapsing inflammatory skin disease 
characterized by severe dryness of the skin and pruritus (Thestrup-Pedersen, 2000). It is currently regarded as a 
multifactorial disorder caused by multiple pathogenetic elements, including genetic predispositions, 
environmental triggers, immune dysfunctions, and skin barrier defects (Novak, Bieber, & Leung, 2003; Bieber, 
2010). 
Typically, an episodic event of exacerbation and remission occurs during early childhood. In Korea, the latest 
12-month prevalence rate in a national epidemiological study has been reported to be up over 15% among 
8-11-year-old children (Jee et al., 2009; Suh et al., 2011), as opposed to 9% among 13-14-year-old children in 
Malaysia and Singapore (Lee & Detzel, 2015). Thus, atopic dermatitis has become a common child health 
problem in Asia as well. 
In Korea, more than half of all patients visiting hospitals for atopic dermatitis treatment were children less than 9 
years of age (Yi & Kim, 2015). Thus, mothers who are the primary caregivers for children with atopic dermatitis 
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are expected to play an important role in managing their children’s symptoms. Because the treatment of atopic 
dermatitis is based partly on educating the patient about proper skin care and the application of topical steroids 
and emollients, disease control is highly dependent on parents’ management abilities. However, these mothers 
may experience stress when they fail to manage their children’s illness as prescribed and recommended (Lawson, 
Lewis-Jones, Finlay, Reid, & Owens, 1998). Thus, providing psycho-educational support to primary caregivers, 
especially mothers, is believed to produce positive treatment outcomes (Ersser, Latter, Sibley, Satherley, & 
Welbourne, 2007). 
Since Bandura introdued the concept of self-efficacy, which refers to a person’s beliefs in his/her capabilities to 
produce given results, this concept has been extensively used in health-related studies (Bandura, 1977, 2006). 
Parent self-efficacy is thought to be a particularly useful indicator for assessing the effectiveness of managing 
children’s chronic diseases (Ersser et al., 2007; Mitchell & Fraser, 2011).  
The Parental Self-Efficacy with Eczema Care Index (PASECI) was originally developed by Ersser et al. in 
England to measure parent self-efficacy in managing various aspects of their children’s atopic dermatitis (Ersser 
et al., 2008). Thereafter, in Australia Mitchell and Fraser (2011) modified and verified the scale using a 
community sample of parents of children with atopic dermatitis. Futhermore, self-efficacy as measured by the 
PASECI was found to mediate the effects of child behaviour difficulties on the performance of atopic dermatitis 
management tasks (Mitchell, Fraser, Ramsbotham, Morawska, & Yates, 2015).  
The purpose of this study was to adapt the PASECI developed in English language countries to the Korean 
language and evaluate its psychometric properties for use in the accurate measurements of mothers’ self-efficacy 
when caring for children with atopic dermatitis in Korea. 
2. Method 
2.1 Study Design 
This study used a prospective cross-sectional design. 
2.2 Development of the Korean version of the PASECI (K-PASECI) 
Beaton et al. (2000)’s guidelines for the cross-cultural adaptation of self-report measures were used to develop 
the Korean version of the PASECI (K-PASECI) in this study (Beaton, Bombardier, Guillemin, & Ferraz, 2000). 
Permission to use the scale was received from the author (Mitchell) prior to the implementation of the study. 
For the first step, two bilingual translators whose mother tongue was Korean independently translated the 
original questionnaire into Korean. One translator was aware of the concept of atopic dermatitis and provided 
equivalency from a more clinical perspective, whereas the other translator did not have a medical or clinical 
background and was not informed concerning atopic dermatitis. Following completion of the independent 
translation into Korean, two translators reviewed and agreed on the synthesized version of the questionnaire. 
Two other bilingual translators whose mother tongue was English back-translated the synthesized questionnaire 
into English and checked the validity of the translated version.  
Next, an expert committee comprising two atopic dermatitis specialists and a paediatric nursing faculty member 
independently reviewed the translated scale for cross-cultural equivalence and readability. The content validity 
index (CVI) was used to objectively assess the measure’s content validity on a 4-point scale (1=very reasonable; 
4-point=very reasonable). All items but one was rated as either 3 or 4, resulting in an average of 3.95 points for 
all items. In addition, one research scientist specializing in Korean literature evaluated the appropriateness of the 
vocabulary order and the propriety of the words used in the translated questionnaire, and the scale was revised to 
improve word order and vocabulary, as recommended.  
Finally, the K-PASECI was evaluated for clarity and readability through pre-testing with conducted with three 
mothers of children with atopic dermatitis. Two mothers had children under the age of 4 years, and one mother 
had an 8-year-old child. All mothers reported an understanding of the K-PASECI, except for one mother's 
question about the application of a bandage on a child. Since a bandage may be prescribed in treating severe 
atopic deramtitis, this item was retained in the scale under development. In addition, the expert committee 
validating the content of the scale did not question it.  
The final 25-item K-PASECI was used in the validation of psychometric properties. Each item was scored on an 
11-point Likert scale, with response options ranging from 0 (cannot do at all) to 10 (highly certain can do) points. 
A higher score indicated greater self-efficacy. This response format was used to maintain congruence with the 
original study. The participants were asked to think about their most recent experiences and select their best 
responses from the full range of choices for each item. 
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2.3 Sample and Setting 
Mothers of children with atopic dermatitis were recruited from outpatient clinics in three tertiary hospitals across 
Korea with paediatric allergy specialists. These clinics were chosen to recruit a representative sample of children 
with varying atopic dermatitis severity in various areas. We used the following inclusion criteria for the children 
with atopic dermatitis: (a) being under 13 years of age; (b) not presenting with other known disease(s) requiring 
medical treatment; (c) having a mother as the primary caregiver.  
2.4 Data Collection 
Mothers who visited the outpatient clinics were referred to the study by their primary care physicians. Parents 
completed the self-reported questionnaire for 15 minutes in the outpatient clinics. The researchers provided 
monetary rewards to all participants. 
A total of 134 mothers participated in this study from March 2013 to August 2014. Nine questionnaires with a 
considerable number of incomplete values were excluded from the final data analysis. The sample size of 125 
was satisfactory for an exploratory factor analysis of the K-PASECI’s 25 items, since about 5 participants per 
item is considered an adequate number (Gorsuch, 1983). 
2.5 Measurements 
The parenting self-efficacy (PSE) scale is used to measure a mother’s general sense of self-efficacy in parenting 
her child (Choe & Chung, 2001). It contains 37 items, including questions on general parenting (11 items), 
health (7 items), communication (9 items), education (6 items), and control (4 items). A 5-point Likert scale, 
ranging from 1 (agree not at all) to 5 (very much agree), was used. A higher total score indicates greater parental 
self-efficacy. This scale demonstrates high internal consistency, with a Cronbach’s α coefficient of .96 for this 
study and .92 in Choe and Chung's (2001) study. 
The severity of atopic dermatitis was also measured using the Patient-Oriented Eczema Measure (POEM) 
(Charman, Venn, & Williams, 2004). The POEM consists of 7 items related to atopic dermatitis symptoms such 
as itching, soreness, sleep disturbance, and skin bleeding. A 5-point scale of frequency of occurrence during the 
previous week was used, ranging from 0 (no days) to 4 (every day), with a higher score indicating greater 
severity of atopic dermatitis. Cronbach’s α was .88 in Charman, Chambers, and Williams's (2003) study and .92 
in this one.  
Participant demographics, including mother’s age and socioeconomic status, child’s age and gender, and 
additional allergic disease(s) and treatment types, were assessed. 
2.6 Data Analysis 
Statistical analysis was performed using SPSS/WIN 21.0. A significance level of .05 was used to indicate 
statistically significant associations. The data were analysed using descriptive statistics based on participant 
demographics. Exploratory factor analysis with varimax rotation was used to verify the internal structure of the 
K-PASECI. Concurrent validity was assessed by examining Pearson’s correlation coefficient between the 
K-PASECI and the PSE. The reliability of the K-PASECI was tested by assessing internal consistency using 
Cronbach’s alpha. Item analysis was conducted to assess inter-item and corrected item-total correlations for 
indications of item incongruence or redundancy. 
2.7 Ethical Consideration 
This study was approved by the Institutional Review Board (IRB) at Y University (No. 2013-0049), with which 
the principal researcher is affiliated. An approval (BD2014-026) was also obtained from C Hospital, one of the 
data collection sites. The other two data collection sites accepted the approval of Y University’s IRB. All 
participants were informed they could withdraw from the study at any time, and they completed a written 
informed consent form in advance of their participation in this study. 
3. Results 
3.1 Demographic Characteristics 
Participant demographics are shown in Table 1. Mothers’ mean (SD) age was 36.84 (3.84) years (range: 28-45 
years). Most mothers had more than a college education, and there was a wide range for family income. 
Regarding children’s characteristics, 77 (61.6%) were boys, and the mean age (SD) was 4.59 (3.47) years (range: 
1-13 years). Forty-eight (38.4%) children had no comorbidity, 38 (30.4%) had rhinitis, 13 (10.4%) had urticarial, 
and 10 (8%) had asthma. Most of the mothers reported using moisturizers (80.0%) and ointments (including 
steroids) (79.2%). The mean severity of the children’s atopic dermatitis was 8.16 (7.78), ranging from 0 to 28.  
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Table 1. Participant demographics (n=125)  























Atopic dermatitis severity 
Atopic dermatitis management  
self-efficacy 







≥3000 and <5000 











Ointment (including steroids) 
Moisturizer 
Immunotherapy 































3.2 Factor Analysis of the K-PASECI 
In the preliminary assessment for factor analysis, the Kaiser-Meyer-Olkin (KMO) assessment exceeded 0.90 for 
the K-PASECI, indicating very high sampling adequacy (Charman et al., 2004). Bartlett’s test of sphericity 
reached statistical significance (χ²=2611.575, p<.001), indicating that the K- PASECI was suitable for factor 
analysis. Principal components analysis for the K-PASECI revealed the presence of four components with 
eigenvalues exceeding 1. These four factors together explained 69.35% of the variance, with each component 
explaining between 7.95% and 27.85% of the variance (Table 2). The four factors were as follows: managing 
children’s symptoms and behaviours (Factor 1), communicating with medical staff (Factor 2), managing 
medication (Factor 3), and using a moisturizer as routine management (Factor 4). The loading of each of these 
items was between .46 and .86, exceeding .40. 
3.3 Internal Consistency 
The internal consistency for the K-PASECI was acceptable, with a Cronbach’s α coefficient of .94. Internal 
consistency was marginally improved by the deletion of Items 3 and 5 (α=.95) (Table 2). 
 












Original factor 1. Performing routine atopic dermatitis management tasks (a=.84)  
Q2 Apply moisturisers to your child’s eczema .86 .94 
Q1 Choose a moisturiser that is suitable for your child .82 .94 
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Q4 Correctly use steroid creams for your child .81  .94 
Q3 Apply antibiotic creams to your child’s eczema .73  .95 
Q5 Apply dressings/bandages to your child’s eczema 
when necessary   .59  .95 
Q8 Judge whether the treatments/medication for your 
child's eczema works   .46  .94 
Q22 Ask the GP to explain things when you don't
understand  .85   .94 
Q21 Tell the GP when your child’s eczema is not
getting better  .83   .94 
Q24 Decide when to call in help form the GP or nurse .81  .94 
Q25 Ask to see a specialist doctor .80  .94 
Q9 Ask a GP if you want to change your child's
medications  .75   .94 
Q23 Tell the GP when you disagree with him/her .73  .94 
Q10 Ask a specialist if you want to change your child's
medications  .64   .94 
Q6 Make the right choice of treatment options if the 
symptoms of your child’s eczema become worse .59    .94 
Q7 Take appropriate action if you think your child’s
eczema has become infected .64    .94 
Original factor 2. Managing the child's symptoms and behaviour (a=.85)  
Q12 Help your child to get involved in managing their
eczema .82    .94 
Q14 Help your child fit his/her eczema into a normal
lifestyle .82    .94 
Q15 Manage to avoid things that irritate/aggravate 
your child’s Eczema .79    .94 
Q11 Manage your child’s scratching behaviour so as to 
stop further skin damage .77    .94 
Q13 Get your child to follow his/her management plan 
even when s/he may be reluctant .77    .94 
Q17 Control your child’s eczema so that he/she can 
play like other children .77    .94 
Q18 Manage your child’s eczema so that his/her 
symptoms are under control .73    .94 
Q19 Reduce any sleep disturbance brought about by 
your child’s eczema .72    .94 
Q16 Adjust your child’s management plan to allow for 
changes in your family’s schedule .69    .94 
Q20 Get access to a health care professional if you 
need to speak to them about your child’s eczema  .73   .94 
Rotated eigenvalue 6.96 5.76 2.63 1.99  
Percentage of variance explained (%) 27.85 23.05 10.50 7.95  
Cumulative percentage of total variance explained (%) 27.85 50.90 61.40 69.35  
 
3.4 Construct Validity 
There was a moderate positive correlation between the K-PASECI and the PSE (r=.48, p<.001), with higher 
K-PASECI scores being associated with higher PSE scores. A moderate positive correlation was found between 
the K-PASECI and all PSE subscales: general parenting (r=.41, p<.001), health (r=.50, p<.001), communication 
(r=.35, p<.001), education (r=.44, p<.001), and control (r=.52, p<.001) (Table 3). 
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Table 3. Correlations between K-PASECI and parenting self-efficacy (n=125) 
 
Subscale of Parenting self-efficacy
Total 
General parenting efficacy Health Communication Education Control 




In Mitchell and Fraser’s (2011) study, a community-based population was used to validate the scale; however, 
this study recruited mothers of children with atopic dermatitis from three hospital-based clinics to represent the 
diversity in the atopic dermatitis child population. The children in this study were younger, with a mean age of 
4.59 years, than those in the previous study, who had a mean age of 6.68 years (Mitchell & Fraser, 2011). 
Mothers of younger children may have more difficulty managing their children’s symptoms, especially in terms 
of communication and behavioural problems (Gelmetti et al., 2012). Disease severity in this study was also 
higher than that reported in several previous studies (Charman et al., 2004; Schram et al., 2012). This seems to 
reflect the younger ages and enhanced severity of atopic dermatitis among Korean children, further supporting 
the use of this scale.  
Parents who have to handle severe atopic dermatitis may need more instruction regarding management tasks to 
follow the prescriptions and to increase their self-efficacy to produce more positive outcomes. Caring for 
children with moderate to severe atopic dermatitis has been shown to be more stressful for parents and families 
than caring for children with insulin-dependent diabetes mellitus (Beattie & Lewis-Jones, 2006; Su, Kemp, 
Varigos, & Nolan, 1997). In addition, more than half the children who participated in this study had comorbid 
allergic diseases such as asthma, allergic rhinitis, and urticaria. A comorbid disease and moderate to severe 
atopic dermatitis may negatively affect both parental self-efficacy and quality of life for mothers caring for 
children with atopic dermatitis. The K-PASECI can thus be used for parents of younger children with moderate 
disease severities, which likely play an important role in effectively managing atopic dermatitis. 
The principal component factor analysis revealed the presence of four components that explained 69.35% of the 
total variance. In contrast, the original instruments were reported to have two factors: performing routine atopic 
dermatitis management tasks (Factor 1) and managing children’s symptoms and behaviours (Factor 2). The 
K-PASECI comprises four factors: managing children’s symptoms and behaviours (Factor 1), communicating 
with medical staff (Factor 2), managing medication (Factor 3), and using a moisturizer as part of the routine 
management (Factor 4). Factor 1 in the original scale, performing routine atopic dermatitis management tasks, 
was broken down into three factor structures to include communicating with medical staff, managing medication, 
and using a moisturizer. In Korea, parents seem to believe that a requirement for self-efficacy regarding the 
management of atopic dermatitis is the ability to communicate with medical staff. A good relationship with the 
physician has been frequently reported as an important contributing factor in the adherence to prescriptions 
(Ohya et al., 2001). Parental self-efficacy concerning treatment management can therefore be strengthened by 
good doctor-mother relationships. 
Interestingly, the structure regarding the management of medication was separated from using moisturizers in the 
performing routine atopic dermatitis management task structure. This indicates that the self-efficacy of 
moisturizer use was considered to be different from that of managing medications. This suggests that 
information on how to select and apply the appropriate moisturizer needs to be provided in clinics as well. 
The construct validity of the K-PASECI has been confirmed, and the measure was shown to have a moderate 
correlation with parenting self-efficacy. The strength of correlation is higher than that between the original 
modified PASECI and the general perceived self-efficacy scale, as reported in the study by Mitchell and Fraser 
(2011). The general perceived self-efficacy scale is supposed to measure an individual’s global and stable 
confidence in his/her ability to deal effectively with challenging or stressful situations. Although the K-PASECI 
focuses on confidence in atopic dermatitis task management while parenting self-efficacy focuses on typical 
child-rearing task-oriented confidence, both scales seem to have similar attributes regarding the concept of 
self-efficacy. Therefore, studies investigating mothers’ disease-specific self-efficacy may be better suited to 
measure self-efficacy as an outcome of intervention with parents of children with atopic dermatitis. 
The internal consistency of the K-PASECI proved to be acceptable, with a value higher than the .89 found in a 
previous study (Mitchell & Fraser, 2011). In the corrected item-total correlation, two items-antibiotic cream 
application and dressing/bandage application-were lower, although they were still within the acceptable ranges 
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of>.30. This seems to reflect the cultural respondent situation in that these items are rarely prescribed by 
outpatient clinic physicians in Korea. 
Although it has satisfactory validity and reliability for use in hospital-based populations of children with 
moderate atopic dermatitis, the K-PASECI must be tested in more diverse demographic samples with varying 
degrees of disease severity. It is recommended that future research examine other family members and/or 
caregivers, since many young children are cared for and educated in preschools due to high maternal 
employment rates. Future studies may also need to investigate the characteristics of mothers with low 
self-efficacy to identify these mothers and provide them with intensive psychosocial and educational care. 
Studies are also needed to evaluate the factor model using confirmatory factor analysis with large samples. 
The self-efficacy of a primary caregiver, such as a mother, is a key component to producing positive outcomes in 
the treatment of a child’s atopic dermatitis. Assessing mothers’ self-efficacy using the K-PASECI may prove 
helpful in investigating the effectiveness of educational interventions provided in relation to managing children’s 
atopic dermatitis in clinical practice and research settings. 
5. Conclusion 
The PASECI, developed and validated by Mitchell and Fraser, is a promising measure of parents’ self-efficacy 
for managing various aspects of their child’s atopic dermatitis (Mitchell & Fraser, 2011). In this study, the 
reliability and validity of the K-PASECI was evaluated using a sample of Korean mothers with children with 
atopic dermatitis who visited hospital outpatient clinics. The K-PASECI was found to be a reliable and valid 
instrument for measuring mothers’ self-efficacy in Korea, where no standardized tool is avaliable for parents of 
child with atopic dermatitis. Both the K-PASECI and original PASECI can be further utilized in multicultural 
centres in English-speaking countries. 
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